In a different study, using an in vivo model of murine pancreatic cancer, we showed that blocking the activation of RAGE using a RAGE-specific monoclonal antibody significantly reduced the protein levels of HMGB1 in tumors, suggesting that RAGE regulated the expression of HMGB1 in pancreatic cancer [60]. The gene discussed is HMGB1; the disease is pancreatic neoplasm.